The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISA 2022 | Session highlights: closing the gap of basic and clinical research in AL and ATTR amyloidosis
Vittorio Bellotti, MD, PhD, University of Pavia, Pavia, Italy, briefly highlights some of the topics that were presented in a session at ISA 2022, which focused on closing the gap of basic and clinical research in amyloidosis. Dr Bellotti also discusses the value of generating and improving models used to understand the biology of this disease. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
